Publicacions
-
Palmerini E, Meazza C, Tamburini A, Márquez-Vega C, Bisogno G, Fagioli F, Ferraresi V, Milano GM, Coccoli L, Rubio-San-Simón A, Gallego O, Llinares Riestra ME, Manzitti C, Mora J, Vaz-Salgado MÁ, Luksch R, Mata C, Pierini M, Carretta E, Cesari M, Paioli A, Marrari A, Scotlandi K, Serra M, Asaftei SD, Gambarotti M, Picci P, Ferrari S, Valverde C, Ibrahim T and Broto JM.
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.
JOURNAL OF CLINICAL ONCOLOGY . 43(28): 3113-3122.
-
Sentís I, Melero JL, Cebrià A, Grzelak M, Soto M, Michel A, Rovira Q, Rodriguez-Hernandez CJ, Caratù G, Urpi A, Sauvage C, Mendizabal-Sasieta A, Maspero D, Lavarino C, Pascual-Reguant A, Castañeda-Heredia A, Muñoz Perez JP, Mora J, Harari A, Nieto JC, Avgustinova A and Heyn H.
Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer.
Annals of oncology : official journal of the European Society for Medical Oncology . 36(9): 1096-1106.
-
Ana Carolina Izurieta Pacheco, Noyd DH, Challinor J, Rossell N, Olarte-Sierra MF, Blanco DB, Zubieta M, George NB, Pérez-Jaume S, Felip-Badia A, Trigoso V, Loggetto P, Gonzalez V, Frias C, Rincon S, Ortiz R, de Aparicio SF and Ponce LV.
Childhood Cancer Survivors in Latin America: Insights Into Health Outcomes and Information Needs
PEDIATRIC BLOOD & CANCER . 72(9): .
-
Pérez-Bertólez S, Salcedo P, Tapia L, Domenech A, Oriol Martín Solé and Garcia-Aparicio L.
Retrocaval ureter: a narrative review.
Translational Andrology and Urology . 14(8): 2456-2466.
-
CastilloSD, Perosanz X, Ressler AK, Ivars M, Rodriguez J, Rovira-Zurriaga C, Nola EM, Llena J, Grego-Bessa J, Roldan-Molina M, Arnau R, Martínez-Romero A, Barber-Martínez de la Torre I, Miguel Bejarano Serrano, Vicente-Villa MA, Celis-Passini V, Salvador-Hernandez H, Mora J, Marchuk DA, Baselga E and Graupera M.
Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
CANCER DISCOVERY . 15(7): 1350-1362. Nº de cites: 2
-
Balaguer-Lluna L, Gene-Olaciregui N, Aschero MR, Resa-Parés C, Paco-Mercader S, Cuadrado-Vilanova M, Burgeño-Sandoval V, Baulenas-Farrés M, Monterrubio C, Manzanares-Quintela A, Rodriguez E, Lavarino C, Mora J and Carcaboso AM.
Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas
JOURNAL OF NEURO-ONCOLOGY . 172(3): 599-611. Nº de cites: 2
-
Chicón-Bosch, M, Sánchez-Serra, S, Rosàs-Lapeña, M, Costa-Fraga, N, Besalú-Velázquez, J, Illa-Bernadí, J, Mateo-Lozano S, Cidre-Aranaz, F, Grünewald, TGP, Díaz-Lagares, A, Lopez-Alemany, R and Tirado, OM.
Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasis
MOLECULAR ONCOLOGY . 19(4): 1002-1028.
-
Mora J, Chan GCF, Morgenstern DA, Amoroso L, Nysom K, Faber J, Wingerter A, Bear MK, Rubio-San-Simon A, de Las Heras BM, Tornøe K, Düring M and Kushner BH.
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial
NATURE COMMUNICATIONS . 16(1): 1636-1636. Nº de cites: 3
-
Cristina Larrosa Espinosa, Simao-Rafael M, Salvador-Marcos N, Muñoz JP, Lavarino C, Chantada G and Mora J.
Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy
Frontiers in pediatrics . 12: 1509645-1509645. Nº de cites: 2
-
Hernandez-Munoz, Inmaculada, Cuervas, Irene, Prada, Estela, Pulecio, Julian, Giemno, Ramon, Andrades, Evelyn, Gomez-Gonzalez, Soledad, Berenguer-Molins, Pau, Acedo-Terrades, Ariadna, Perera-Bel, Julia, Bodalo, Marta, Nonell, Lara, Perez, Elena, Grases, Daniela, Mata, Caterina, Yelamos, Jose, Richaud, Yvonne, Vidal, Enrique, Cuartero, Yasmina, Le Dily, Francois, Sunol, Mariona, Manzanares, Alejandro, Raya, Angel and Mora J.
EWS-FLI1 Expression in Human Embryonic MSCs Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma
Biorxiv . : .
